UNICA IRIS Institutional Research Information System

CRISPONI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 181.869
NA - Nord America 13.212
AS - Asia 5.210
SA - Sud America 765
AF - Africa 116
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 201.190
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 175.371
US - Stati Uniti d'America 13.045
NL - Olanda 2.943
SG - Singapore 2.041
CN - Cina 1.945
UA - Ucraina 1.128
SE - Svezia 638
BR - Brasile 593
DE - Germania 510
FI - Finlandia 418
VN - Vietnam 398
GB - Regno Unito 337
FR - Francia 281
KR - Corea 155
IN - India 142
HK - Hong Kong 132
CA - Canada 108
AR - Argentina 61
RU - Federazione Russa 57
BD - Bangladesh 49
IQ - Iraq 40
TR - Turchia 40
MX - Messico 39
JP - Giappone 38
ES - Italia 34
IR - Iran 33
BE - Belgio 26
EC - Ecuador 26
ID - Indonesia 25
ZA - Sudafrica 22
AT - Austria 21
PK - Pakistan 21
PH - Filippine 20
PL - Polonia 20
CO - Colombia 18
UZ - Uzbekistan 18
CL - Cile 16
MA - Marocco 16
SA - Arabia Saudita 16
TN - Tunisia 16
AU - Australia 15
CH - Svizzera 15
MY - Malesia 15
EG - Egitto 13
UY - Uruguay 13
VE - Venezuela 12
PE - Perù 11
SY - Repubblica araba siriana 11
DZ - Algeria 9
IE - Irlanda 9
KE - Kenya 9
PY - Paraguay 9
NG - Nigeria 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
JO - Giordania 7
MU - Mauritius 7
RO - Romania 7
BG - Bulgaria 6
ET - Etiopia 6
BO - Bolivia 5
CR - Costa Rica 5
GR - Grecia 5
IL - Israele 5
NP - Nepal 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
BY - Bielorussia 4
JM - Giamaica 4
LB - Libano 4
PS - Palestinian Territory 4
RS - Serbia 4
AM - Armenia 3
CI - Costa d'Avorio 3
KZ - Kazakistan 3
LT - Lituania 3
MD - Moldavia 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
IS - Islanda 2
KG - Kirghizistan 2
KH - Cambogia 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
SN - Senegal 2
TW - Taiwan 2
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
Totale 201.177
Salva come PNG Salva come JPEG
Città #
Cagliari 172.002
Amsterdam 2.923
Uta 2.568
Fairfield 1.440
Ashburn 1.097
Woodbridge 1.072
Singapore 959
Houston 804
Chandler 767
San Jose 662
Dallas 621
Wilmington 609
Jacksonville 607
Ann Arbor 597
Boardman 581
Seattle 554
Cambridge 508
Nyköping 439
Dearborn 295
Beijing 259
Helsinki 237
Los Angeles 208
Nanjing 197
Hefei 183
Lauterbourg 170
Boston 160
Seoul 145
The Dalles 141
Ho Chi Minh City 132
Hong Kong 123
Santa Clara 123
Hanoi 105
New York 96
Buffalo 93
Shanghai 91
Nanchang 70
San Diego 70
Escalaplano 69
Guangzhou 67
Milan 64
São Paulo 58
Shenyang 56
Hebei 52
Redwood City 52
Tianjin 50
Changsha 47
Council Bluffs 45
Toronto 45
Jiaxing 43
Redondo Beach 39
Verona 36
Mountain View 34
Orem 34
Atlanta 33
Norwalk 33
Dong Ket 30
London 30
Zhengzhou 30
Orange 29
Sassari 28
Frankfurt am Main 27
Tokyo 27
Brussels 26
Jinan 26
Ottawa 25
Chennai 24
Ningbo 22
Pune 22
Chicago 20
Rio de Janeiro 20
Rome 18
Auburn Hills 17
Hangzhou 17
Nuremberg 17
Washington 17
Brooklyn 16
Cedar Knolls 16
Pars 16
Tashkent 15
Warsaw 15
Haiphong 14
Da Nang 13
Manchester 13
Phoenix 13
Stockholm 13
Bari 12
Curitiba 12
San Francisco 12
Turku 12
Baghdad 11
Columbus 11
Dhaka 11
Falls Church 11
Wuhan 11
Belo Horizonte 10
Fuzhou 10
Jakarta 10
Kunming 10
Mumbai 10
Ankara 9
Totale 193.343
Salva come PNG Salva come JPEG
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.748
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.844
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.626
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.548
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.531
Multiple Sclerosis and environmental factors. 3.291
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.933
Sampling variability in hepatic iron concentration in beta-thalassemia 2.871
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.795
The essential metals for humans: a brief overview 2.703
Looking at new ligands for chelation therapy 2.560
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.442
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.410
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.297
Gold nanoparticles: A new golden Era in oncology? 2.274
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.228
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.225
Do anti-diabetic drugs act as copper ligands? 2.210
Toxicity of nanoparticles: etiology and mechanisms 2.152
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.114
Arsenic toxicity: Molecular targets and therapeutic agents 2.077
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.074
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.037
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 2.029
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.972
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.965
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.957
Kill or cure: Misuse of chelation therapy for human diseases 1.923
The meaning of aluminium exposure on human health and aluminium-related diseases 1.911
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.893
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.892
Silver coordination compounds: A new horizon in medicine 1.868
Alarming use of chelation therapy 1.847
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.835
Chemical features of in use and in progress chelators for iron overload 1.826
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.822
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.797
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.796
State of art in chelating agents for the clinical treatment of metal poisoning 1.791
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.777
Noble metals in medicine: Latest advances 1.777
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.764
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.734
Chelating agents as therapeutic compounds - Basic principles 1.712
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.708
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.673
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.650
Uneven hepatic copper distribution in Wilson's disease 1.611
Chelating agents for human diseases related to aluminium overload 1.558
Uneven cardiac iron distribution in beta-thalassemia 1.511
Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips 1.420
Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine 1.352
Chelating agents for metal intoxication 1.305
The Potential Clinical Properties of Magnesium 1.299
Iron chelating agents for iron overload diseases 1.237
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.237
Metal ion toxicity 1.234
Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology 1.208
Warns against unapproved ‘chelation therapy’ 1.199
null 1.188
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.161
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.158
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.150
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.113
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson’s disease and beta-thalassemia 1.086
null 1.075
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.070
A new hydroxypyrone chelating agent for FeIII and AlIII: a structural and equilibrium study 1.055
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 1.055
Kojic derivatives: a promising class of iron(III) chelators 1.001
A spectroscopic study on ionization of 2-, 3- and 4-aminopyridines 978
Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator 958
Enhancement of g-aminobutyric acid binding by Quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors 957
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 937
The outer/inner sphere dichotomy in the reaction of some adenine-like N-ligands with [Cu(H2EDTA)(H2O)] chelate 918
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 903
Aluminium dependent human diseases, and chelating properties of aluminium chelators for bio-medical applications 891
Nickel binding sites in histone proteins: spectroscopic and structural characterization 881
A Chemometric analysis of metal ion content in Sardinian wines 850
null 845
Manganese and cobalt binding in a multi-histidinic fragment 836
Preface 814
Anomalies of the oral cavity in newborns 783
Stress and ß-carbolines decrease the density of low affinity Gaba binding sites; an effect reversed by diazepam 772
Complex formation equilibria of copper(II) with triethylentetramine and its human acetyl metabolites 768
Calculation of spectra parameters in several spectra by contemporary decomposition in the constituent Gaussian peaks 754
Divalent metal-acetate complexes in concentrated aqueous solutions. An X-ray diffraction and NMR spectroscopy study 743
Structural correlations in nickel(II)-thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)(3)] 720
Changes in the characteristics of low affinity of Gaba binding sites elicited by Ro15-1788 716
SUBSTITUENT EFFECTS OF NITRO GROUP ON THE COMPLEX FORMATION EQUILIBRIA OF SALICYLIC ACID AND CATECHOL WITH Fe(III) AND Al(III) IONS 701
Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease 692
Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues 689
Thiodiacetato-copper(II) chelates with or without N-heterocyclic donor ligands: molecular and/or crystal structures of [Cu(tda)](n), [Cu(tda)(Him)(2)(H2O)] and [Cu(tda)(5Mphen)] center dot 2H(2)O (Him = imidazole, 5Mphen=5-methyl-1,10-phenanthroline) 681
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson and beta-thalassemia 681
null 678
Equilibrium constants of the Fe(III)dopamine system in aqueous solution 669
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrais(mu(2)-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II) 668
null 666
Uneven element distribution in alcoholic liver disease. A case report 643
THIODIACETATE-COPPER(II) CHELATES WITH OR WITHOUT N-HETEROCYCLIC DONOR LIGANDS. CRYSTAL STRUCTURES OF [CU(TDA)]N, [CU(TDA)(HIM)2(H2O)] AND [CU(TDA)(5MPHEN)].2H2O 641
Totale 159.625
Salva come PNG Salva come JPEG
Categoria #
all - tutte 270.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 270.976
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.565 0 0 0 0 0 0 0 0 0 2.699 2.162 1.704
2021/20228.541 1.083 959 497 772 751 678 521 326 596 687 881 790
2022/202311.356 922 1.154 1.175 826 942 1.268 548 1.937 802 571 719 492
2023/202412.856 746 532 575 997 1.394 2.210 1.777 829 517 1.068 1.120 1.091
2024/202528.715 7.253 7.466 3.352 2.552 1.431 1.515 2.380 203 420 1.370 319 454
2025/202610.284 563 379 1.242 736 530 708 1.920 658 2.798 750 0 0
Totale 201.607